Market Cap 14.05B
Revenue (ttm) 680.85M
Net Income (ttm) -74.68M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE 285.17
Profit Margin -10.97%
Debt to Equity Ratio 0.00
Volume 16,062,900
Avg Vol 2,581,098
Day's Range N/A - N/A
Shares Out 106.52M
Stochastic %K 77%
Beta 0.46
Analysts Sell
Price Target $126.00

Latest News on ITCI

Top 4 Health Care Stocks You May Want To Dump In Q1

Jan 21, 2025, 6:06 AM EST - 2 months ago

Top 4 Health Care Stocks You May Want To Dump In Q1

BBIO BSX ISRG


Johnson & Johnson to Acquire Intra-Cellular in $15 Billion Deal

Jan 13, 2025, 3:13 PM EST - 2 months ago

Johnson & Johnson to Acquire Intra-Cellular in $15 Billion Deal

JNJ


J&J to buy Intra-Cellular Therapies for $14.6 billion

Jan 13, 2025, 6:38 AM EST - 2 months ago

J&J to buy Intra-Cellular Therapies for $14.6 billion

JNJ


This Stock Is Soaring Amid J&J Takeover Report

Jan 13, 2025, 5:41 AM EST - 2 months ago

This Stock Is Soaring Amid J&J Takeover Report


Intra-Cellular Brightens MDD Outlook With Caplyta Success

Jun 19, 2024, 2:08 AM EDT - 10 months ago

Intra-Cellular Brightens MDD Outlook With Caplyta Success